| BCYRN1 |
|
brain cytoplasmic RNA 1
|
|
|
0.666 |
0.423 |
| EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
| FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
| FTH1P3 |
|
ferritin heavy chain 1 pseudogene 3
|
|
|
0.751 |
0.269 |
| HOXA@ |
|
homeobox A cluster
|
|
|
0.599 |
0.654 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| SCLC1 |
|
small cell cancer of the lung
|
|
|
0.612 |
0.577 |
| SNHG3 |
|
small nucleolar RNA host gene 3
|
|
|
0.682 |
0.385 |
| MMP23A |
|
matrix metallopeptidase 23A (pseudogene)
|
|
|
0.722 |
0.308 |
| KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
| PTENP1 |
|
phosphatase and tensin homolog pseudogene 1
|
|
|
0.650 |
0.577 |
| LINC00328 |
|
long intergenic non-protein coding RNA 328
|
|
|
0.608 |
0.692 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| CEBPA-DT |
|
CEBPA divergent transcript
|
|
|
0.821 |
0.115 |
| CYTOR |
|
cytoskeleton regulator RNA
|
|
|
0.568 |
0.577 |
| ANIB1 |
|
aneurysm, intracranial berry 1
|
|
|
0.608 |
0.500 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| LINC00662 |
|
long intergenic non-protein coding RNA 662
|
|
|
0.751 |
0.231 |
| FEZF1-AS1 |
|
FEZF1 antisense RNA 1
|
|
|
0.644 |
0.615 |
| HOXA11-AS |
|
HOXA11 antisense RNA
|
|
|
0.610 |
0.423 |